Medullar damage in posterior horns, initial manifestation of multiple myeloma. Med Int Méx 2022; 38 (4): 942-947. https://doi.org/10.24245/mim.v38i4.4468 Alfonso Rodríguez-Ojeda,1 Fanny Aguas-Arce,2 Josefina García-González,3 Luisa Banda-García4 1 Residente de Medicina Interna. 2 Especialista en Medicina Interna 3 Especialista…
Deep vein thrombosis associated to mutation in factor V Leiden, MTHFR and May-Thurner syndrome. Med Int Méx 2022; 38 (4): 933-941. https://doi.org/10.24245/mim.v38i4.4453 Oscar Villagómez-Figueroa,1 Héctor Infante-Sierra,2 Manuel Marquina-Ramírez,3 Roberto Castañeda-Gaxiola3 1 Hospital de Especialidades Dr. Belisario…
Spectrum of neuromyelitis optica and medullary failure syndrome secondary to azathioprine. Med Int Méx 2022; 38 (4): 928-932. https://doi.org/10.24245/mim.v38i4.4414 José Daniel Martínez-Mondragón,1 Ximena Torres-Cabrera,1 Juan Carlos Morales-Pascacio,1 José Luis Torres-Cuevas,2 José Luis Torres-Escalante3 1 Residente de Medicina…
Nephrotic syndrome as initial manifestation of Hodgkin lymphoma. Med Int Méx 2022; 38 (4): 921-927. https://doi.org/10.24245/mim.v38i4.4362 Andrés Aguilar-Silva,1 Luis Del Carpio-Orantes,2 Alma Arely García-Nieva,3 Josué Elí Villegas-Domínguez4 1 Residente de segundo año de Medicina Interna, Unidad…
Stigmatization of patients with obesity in the medical and social context. Med Int Méx 2022; 38 (4): 914-920. https://doi.org/10.24245/mim.v38i4.6831 Christian Emmanuel Guendulain-Sernas,1 Isaías Hernández-Torres,2 Geovani López-Ortiz3 1 Médico pasante de servicio social de la licenciatura…
Homocysteina, another cardiovascular risk factor. Med Int Méx 2022; 38 (4): 903-913. https://doi.org/10.24245/mim.v38i4.6779 Guillermo Murillo-Godínez Medicina Interna, Querétaro, Qro., México. ANTECEDENTES La hiperhomocisteinemia se ha considerado factor de riesgo independiente cardiovascular y…
Clinical use of neurotropic B vitamins in diseases of the peripheral nervous system in Mexico and Central America. Med Int Méx 2022; 38 (4): 887-902. https://doi.org/10.24245/mim.v38i4.5133 Carlos-Alberto Calderón-Ospina,1 Héctor Gonzalo Franco-González,2 Fernando Leal-Martínez,3 Agni Horacio…
Cytokine release syndrome in infection due to COVID-19 and administration of tocilizumab as therapeutic option. Med Int Méx 2022; 38 (4): 877-886. https://doi.org/10.24245/mim.v38i4.4869 Mónica Prado-Rodríguez, Yovani Robles-Abarca, Brenda Lizette González-Rocha, Fernando Soler-Delgado,…
Clinical criteria of brain death. Med Int Méx 2022; 38 (4): 868-876. https://doi.org/10.24245/mim.v38i4.4527 Jacob García-Regalado,1 José Juan Escoto-López2 1 Departamento de medicina crítica. Hospital General de Zona núm. 21, Instituto Mexicano del Seguro Social,…
Hepatitis C in people who inject drugs in Mexico: an overview. Med Int Méx 2022; 38 (4): 859-867. https://doi.org/10.24245/mim.v38i4.4514 Diana Sánchez-Herrera,1 Raúl Mellado-Orellana,1 Erika Faride Rodríguez-Aguilar2 1 Residente de medicina interna, Hospital Ángeles Pedregal, Ciudad…